Ogłoszenie o zwołaniu Nadzwyczajnego Walnego Zgromadzenia
Na dzień 28 maja 2026 roku zwołane zostało Zwyczajne Walne Zgromadzenie. Wszystkie szczegółowe i niezbędne informacje zamieszczone zostały w poniższych załącznikach.
2) Monitor Sądowy i Gospodarczy
3) Sprawozdanie Zarządu z działalności spółki za 2023
4) Opinia Niezależnego Biegłego Rewidenta za 2023
5) Sprawozdanie Finansowe Spółki za 2023
6) Sprawozdanie Rady Nadzorczej za 2023
Head of the Neurology and Stroke Department at St. Wojciech Hospital in Gdańsk.
Professor at Gdańsk Medical University.
Head of the Neurological-Psychiatric Nursing Department at Gdańsk Medical University.
President of the Polish Neurological Society.
Member of the National Council for Neurology appointed by Minister of Health, Adam Niedzielski.
Specializes in the diagnosis and treatment of neurological disorders, with a particular focus on conditions such as Parkinson's disease and other parkinsonisms, dystonias, choreas (Huntington's disease and others), myoclonus, tics, tremors, and other neurodegenerative diseases.
Secretary of the International Association of Parkinsonism and Related Disorders (IAPRD).
The National Council for Neurology manages the process of modernizing Polish neurology. Its opinions will form the basis for creating appropriate regulations to improve accessibility to diagnosis, therapy, and enhance the quality of care for individuals with neurological conditions. The council places the greatest emphasis on neurodegenerative diseases (such as Alzheimer's and Parkinson's disease, and multiple sclerosis), stroke, and epilepsy. In collaboration with national scientific societies, the council develops and disseminates medical treatment standards for neurological diseases and prepares recommendations on the use of innovative technologies in the diagnosis and treatment of such conditions.
IAPRD was established about 50 years ago and is affiliated with the World Federation of Neurology, with its headquarters in the Netherlands. It is one of the leading organizations worldwide promoting research and clinical knowledge in the field of neurodegenerative diseases and movement disorders. IAPRD publishes the prestigious journal "Parkinsonism & Related Disorders" (Elsevier) and, more recently, its clinically focused extension called "Clinical Parkinsonism & Related Disorders.
Chairman of the Coordinating Team for the Treatment of Motor Disorders in Parkinson's Disease.
Vice-Chairman of the Health Sciences Discipline Council at the Medical University of Warsaw.
Member of the Board of the Section of Extrapyramidal Disorders of the Polish Neurological Society.
Member of the Board of the Polish Neurological Society.
Graduate of the 1st Faculty of Medicine at the Medical University of Warsaw.
Head of the Neurology Clinic, Faculty of Health Sciences at the Medical University of Warsaw, Mazowiecki Bródno Hospital.
Assistant Professor at the Neurology Clinic, Faculty of Health Sciences at the Medical University of Warsaw.
President of the Polish Parkinson's Disease and Movement Disorders Society.
President of the Section of Extrapyramidal Disorders of the Polish Neurological Society.
President of the Extrapyramidal Section of the Polish Neurological Society and the Polish Parkinson's Disease and Movement Disorders Society.
His professional and scientific research focuses on movement disorders (dystonias, Parkinson's disease), mechanisms of neurodegeneration, as well as deep brain stimulation and botulinum toxin therapy.
His interests and research are concentrated on neurodegenerative diseases and movement disorders, covering a wide range from pathogenesis to treatment, including deep brain stimulation.
NEUROLOGY CLINIC
The Neurology Clinic at the Faculty of Health Sciences, Medical University of Warsaw, has been operating for 13 years at the Mazowiecki Bródno Hospital. The clinic currently has 68 beds.
The team includes the Stroke Unit, General Neurology Unit, and Neurorehabilitation Unit.
The clinic is a leading center in Poland for the diagnosis and treatment of extrapyramidal disorders, to which patients from all over Poland are referred for diagnosis and treatment. The clinic manages qualification programs for advanced therapies for patients with Parkinson's disease. The experienced team qualifies patients for deep brain stimulation (DBS), treatment with duodenal levodopa infusion, and subcutaneous apomorphine infusion. All patients remain under the care of the clinic and continue to be treated on-site (in the ward or outpatient clinic). Due to the large number of patients being treated, the clinic's doctors share their extensive experience by organizing numerous lectures and training sessions.
Patients with the most severe brain strokes are treated in two Enhanced Neurological Supervision rooms. Collaboration with the Neurosurgery Department and the Vascular Surgery Clinic allows for modern treatment of diseases of the central nervous system.
The Electroencephalography Laboratory performs diagnostic tests on patients with seizure disorders and brain injuries. The Electromyography Laboratory conducts tests on patients with peripheral nervous system diseases - root inflammations, polyneuropathies, peripheral nerve damage, as well as rarer diseases such as myasthenia gravis and amyotrophic lateral sclerosis.
Specialist clinics run within the clinic: Parkinsonism Clinic, Epilepsy and Headache Clinic, Memory Disorders Clinic, Multiple Sclerosis Clinic, and Neuromuscular Disorders Clinic.
The organization has been one of the driving forces behind changes in the systemic treatment of Parkinson's disease. The Foundation's efforts resulted in the final reimbursement of two previously unavailable therapies in Poland - Duodopa and Dacepton-apomorphine - in 2017.
Wojciech Machajek is also the initiator of the Tulips of Hope award, given to individuals who have made significant contributions to improving the situation of those affected by Parkinson's disease, caregivers, and doctors' knowledge of the condition.
Since 2021, the Foundation has expanded its scope of activities and, therefore, changed its name once again - it now operates as the Brain Diseases Foundation. This step reflects the ambition to utilize acquired experience and knowledge to address the challenges faced by individuals suffering from other neurological diseases in Poland on a daily basis.
Foundation's Goals:
SUPPORT - providing substantive, psychological, and informational support to individuals with neurological diseases, as well as their families and caregivers, whose functioning is often severely impacted by the conditions.
EDUCATION - increasing knowledge about neurological diseases among medical professionals and the general public.
The Brain Diseases Foundation is supported by the Advisory Medical Council,composed of the most distinguished neurologists from various specialties in the country:
1/ Prof. Alina Kułakowska
2/ Dr hab. Alicja Kalinowska
3/ Dr hab. Iwona Sarzyńska-Długosz
4/ Prof. Jarosław Sławek
5/ Dr hab. Dariusz Koziorowski
Specific Objective:
Dr. Sebastian Banaszek, a shareholder and chairman of the supervisory board of IMU Medical S.A., is also a co-author of the IMU Medical inertial wristband patent. He is an expert in acquiring and analyzing medical data, with a particular focus on the application of artificial intelligence and machine learning. His specialization includes the development of advanced algorithms and data analysis methods in the context of medicine.
As a member of the IMU Medical S.A. team, Dr. Banaszek introduces innovative approaches to using sensory data in monitoring patients with dopamine deficiency, especially those suffering from Parkinson's disease. His knowledge and skills are invaluable for the development of our medical solutions, which rely on precise data analysis and provide comprehensive diagnostic information. Dr. Banaszek actively contributes to improving our technologies and adapting them to the needs of patients and medical professionals.
His dedication to the development of IMU Medical and the utilization of the latest advancements in data analysis contribute to the creation of innovative and effective medical solutions that have the potential to improve the quality of life for patients with Parkinson's disease and other disorders.
Artur Książek is one of the co-founders and the President of IMU Medical S.A., as well as a co-author of the IMU Medical inertial bracelet patent. He was also the former President of Prometheus S.A., a renowned drone manufacturer. His extensive experience in technology, particularly related to the use of IMU in drone flight stabilization and management, adds significant value to the development of IMU Medical. Artur Książek is an expert in innovation and entrepreneurship, and his dedication contributes to the creation of innovative medical solutions. As the President of Prometheus S.A., he achieved remarkable success in the technology industry, gaining recognition both in the Polish and international markets. His knowledge, vision, and strategic thinking abilities contribute to the success of IMU Medical, which aims to revolutionize the field of treatment and monitoring of patients with dopamine deficiency. Artur Książek is highly committed to the company's development and strives for global recognition of the innovative medical solutions offered by IMU Medical S.A.
